{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T11:16:22Z","timestamp":1794222982851,"version":"4.8.0"},"reference-count":204,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03352-8","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:20:31Z","timestamp":1746231631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies"],"prefix":"10.1186","volume":"23","author":[{"given":"Sepehr","family":"Mehdizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobin","family":"Mamaghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayyeh","family":"Hassanikia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younes","family":"Pilehvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz Nuri","family":"Ertas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"key":"3352_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12951-023-01778-6","volume":"21","author":"J Zou","year":"2023","unstructured":"Zou J, Yang W, Cui W, Li C, Ma C, Ji X, Hong J, Qu Z, Chen J, Liu A, Wu H. Therapeutic potential and mechanisms of mesenchymal stem cell-derived exosomes as bioactive materials in tendon-bone healing. J Nanobiotechnol. 2023;21:14.","journal-title":"J Nanobiotechnol"},{"key":"3352_CR2","doi-asserted-by":"crossref","unstructured":"Ghorai SM, Deep A, Magoo D, Gupta C, Gupta N. Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood-Brain Barrier (BBB). Pharmaceutics 2023, 15.","DOI":"10.3390\/pharmaceutics15071999"},{"key":"3352_CR3","doi-asserted-by":"publisher","first-page":"121949","DOI":"10.1016\/j.biomaterials.2022.121949","volume":"293","author":"FU Rehman","year":"2023","unstructured":"Rehman FU, Liu Y, Zheng M, Shi B. Exosomes based strategies for brain drug delivery. Biomaterials. 2023;293:121949.","journal-title":"Biomaterials"},{"key":"3352_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","volume":"20","author":"GC Terstappen","year":"2021","unstructured":"Terstappen GC, Meyer AH, Bell RD, Zhang W. Strategies for delivering therapeutics across the blood-brain barrier. Nat Rev Drug Discov. 2021;20:362\u201383.","journal-title":"Nat Rev Drug Discov"},{"key":"3352_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jconrel.2023.05.009","volume":"358","author":"J Liao","year":"2023","unstructured":"Liao J, Fan L, Li Y, Xu Q-Q, Xiong L-Y, Zhang S-S, Liu J-H, Xiao Z-C, Zhang C, Yang J. Recent advances in biomimetic nanodelivery systems: new brain-targeting strategies. J Control Release. 2023;358:439\u201364.","journal-title":"J Control Release"},{"key":"3352_CR6","doi-asserted-by":"publisher","first-page":"2402445","DOI":"10.1002\/adma.202402445","volume":"36","author":"J Liao","year":"2024","unstructured":"Liao J, Gong L, Xu Q, Wang J, Yang Y, Zhang S, Dong J, Lin K, Liang Z, Sun Y. Revolutionizing neurocare: biomimetic nanodelivery via cell membranes. Adv Mater. 2024;36:2402445.","journal-title":"Adv Mater"},{"key":"3352_CR7","doi-asserted-by":"crossref","unstructured":"Liao J, He W, Li L, Wang J, Gong L, Zhang Q, Lin Z. Mitochondria in brain diseases: bridging structural-mechanistic insights into precision-targeted therapies. Cell Biomater. 2025;1:100016.","DOI":"10.1016\/j.celbio.2025.100016"},{"key":"3352_CR8","first-page":"1095","volume":"2","author":"MJ Wood","year":"2011","unstructured":"Wood MJ, \u2018Loughlin O, Lakhal AJ. Exosomes and the blood\u2013brain barrier: implications for neurological diseases. Drug Discov Today. 2011;2:1095\u20139.","journal-title":"Drug Discov Today"},{"key":"3352_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10787-022-01115-7","volume":"31","author":"S Sadeghi","year":"2023","unstructured":"Sadeghi S, Tehrani FR, Tahmasebi S, Shafiee A, Hashemi SM. Exosome engineering in cell therapy and drug delivery. Inflammopharmacology. 2023;31:145\u201369.","journal-title":"Inflammopharmacology"},{"key":"3352_CR10","doi-asserted-by":"publisher","first-page":"11054","DOI":"10.3390\/ijms241311054","volume":"24","author":"A He","year":"2023","unstructured":"He A, Wang M, Li X, Chen H, Lim K, Lu L, Zhang C. Role of exosomes in the pathogenesis and theranostic of Alzheimer\u2019s disease and Parkinson\u2019s disease. Int J Mol Sci. 2023;24:11054.","journal-title":"Int J Mol Sci"},{"key":"3352_CR11","doi-asserted-by":"crossref","unstructured":"Vahab SA, Kumar VVK. VS: Exosome-based drug delivery systems for enhanced neurological therapeutics. Drug Deliv Transl Res. 2024;15:1121\u201338.","DOI":"10.1007\/s13346-024-01710-x"},{"key":"3352_CR12","doi-asserted-by":"crossref","unstructured":"Avgoulas DI, Tasioulis KS, Papi RM, Pantazaki AA. Therapeutic and diagnostic potential of exosomes as drug delivery systems in brain cancer. Pharmaceutics. 2023;15:1439.","DOI":"10.3390\/pharmaceutics15051439"},{"key":"3352_CR13","doi-asserted-by":"publisher","first-page":"843412","DOI":"10.3389\/fphar.2022.843412","volume":"13","author":"Q Wu","year":"2022","unstructured":"Wu Q, Duan W-Z, Chen J-B, Zhao X-P, Li X-J, Liu Y-Y, Ma Q-Y, Xue Z, Chen J-X. Extracellular vesicles: emerging roles in developing therapeutic approach and delivery tool of Chinese herbal medicine for the treatment of depressive disorder. Front Pharmacol. 2022;13:843412.","journal-title":"Front Pharmacol"},{"key":"3352_CR14","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.3390\/cimb46050286","volume":"46","author":"E Louka","year":"2024","unstructured":"Louka E, Koumandou VL. The emerging role of human gut bacteria extracellular vesicles in mental disorders and developing new pharmaceuticals. Curr Issues Mol Biol. 2024;46:4751\u201367.","journal-title":"Curr Issues Mol Biol"},{"key":"3352_CR15","doi-asserted-by":"crossref","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.","DOI":"10.1126\/science.aau6977"},{"key":"3352_CR16","doi-asserted-by":"publisher","first-page":"135851","DOI":"10.1016\/j.ijbiomac.2024.135851","volume":"280","author":"H Zhang","year":"2024","unstructured":"Zhang H, Yan J, Ma Q, Lin L, Pilehvar Y, Zarghami N, Liang L, Xu K, Zhang X, Yan K. Sodium alginate hydrogels co-encapsulated with cell free fat extract-loaded core-shell nanofibers and menstrual blood stem cells derived exosomes for acceleration of articular cartilage regeneration. Int J Biol Macromol. 2024;280:135851.","journal-title":"Int J Biol Macromol"},{"key":"3352_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.addr.2016.02.006","volume":"106","author":"P Vader","year":"2016","unstructured":"Vader P, Mol EA, Pasterkamp G, Schiffelers RM. Extracellular vesicles for drug delivery. Adv Drug Deliv Rev. 2016;106:148\u201356.","journal-title":"Adv Drug Deliv Rev"},{"key":"3352_CR18","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.trecan.2020.03.007","volume":"6","author":"VS LeBleu","year":"2020","unstructured":"LeBleu VS, Kalluri R. Exosomes as a multicomponent biomarker platform in cancer. Trends Cancer. 2020;6:767\u201374.","journal-title":"Trends Cancer"},{"key":"3352_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","volume":"21","author":"M Mathieu","year":"2019","unstructured":"Mathieu M, Martin-Jaular L, Lavieu G, Th\u00e9ry C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21:9\u201317.","journal-title":"Nat Cell Biol"},{"key":"3352_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","volume":"75","author":"NP Hessvik","year":"2018","unstructured":"Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci. 2018;75:193\u2013208.","journal-title":"Cell Mol Life Sci"},{"key":"3352_CR21","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"DF Quail","year":"2017","unstructured":"Quail DF, Joyce JA. The microenvironmental landscape of brain tumors. Cancer Cell. 2017;31:326\u201341.","journal-title":"Cancer Cell"},{"key":"3352_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev-pharmtox-010814-124630","volume":"55","author":"B Gy\u00f6rgy","year":"2015","unstructured":"Gy\u00f6rgy B, Hung ME, Breakefield XO, Leonard JN. Therapeutic applications of extracellular vesicles: clinical promise and open questions. Annu Rev Pharmacol Toxicol. 2015;55:439\u201364.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3352_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ajur.2024.02.003","volume":"11","author":"R Margiana","year":"2024","unstructured":"Margiana R, Pilehvar Y, Amalia FL, Lestari SW, Supardi S. I\u2019tishom R: mesenchymal stem cell secretome: A promising therapeutic strategy for erectile dysfunction? Asian J Urol. 2024;11:391\u2013405.","journal-title":"Asian J Urol"},{"key":"3352_CR24","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/cns.13743","volume":"27","author":"J Mattingly","year":"2021","unstructured":"Mattingly J, Li Y, Bihl JC, Wang J. The promise of exosome applications in treating central nervous system diseases. CNS Neurosci Ther. 2021;27:1437\u201345.","journal-title":"CNS Neurosci Ther"},{"key":"3352_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of SiRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29:341\u20135.","journal-title":"Nat Biotechnol"},{"key":"3352_CR26","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.7150\/thno.92703","volume":"14","author":"J Zhao","year":"2024","unstructured":"Zhao J, Cui X, Zhan Q, Zhang K, Su D, Yang S, Hong B, Wang Q, Ju J, Cheng C, et al. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis\/tmz resistance in the mesenchymal subtype of glioblastoma. Theranostics. 2024;14:2835\u201355.","journal-title":"Theranostics"},{"key":"3352_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jconrel.2024.02.037","volume":"368","author":"JF Creeden","year":"2024","unstructured":"Creeden JF, Sevier J, Zhang JT, Lapitsky Y, Brunicardi FC, Jin G, Nemunaitis J, Liu JY, Kalinoski A, Rao D, Liu SH. Smart exosomes enhance PDAC targeted therapy. J Control Release. 2024;368:413\u201329.","journal-title":"J Control Release"},{"key":"3352_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0223-5","volume":"51","author":"DE Murphy","year":"2019","unstructured":"Murphy DE, de Jong OG, Brouwer M, Wood MJ, Lavieu G, Schiffelers RM, Vader P. Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking. Exp Mol Med. 2019;51:1\u201312.","journal-title":"Exp Mol Med"},{"key":"3352_CR29","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1016\/j.ymthe.2018.09.015","volume":"26","author":"RA Haraszti","year":"2018","unstructured":"Haraszti RA, Miller R, Stoppato M, Sere YY, Coles A, Didiot MC, Wollacott R, Sapp E, Dubuke ML, Li X, et al. Exosomes produced from 3D cultures of MSCs by tangential flow filtration show higher yield and improved activity. Mol Ther. 2018;26:2838\u201347.","journal-title":"Mol Ther"},{"key":"3352_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E. Astrocyte\u2013endothelial interactions at the blood\u2013brain barrier. Nat Rev Neurosci. 2006;7:41\u201353.","journal-title":"Nat Rev Neurosci"},{"key":"3352_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","volume":"16","author":"P Ballabh","year":"2004","unstructured":"Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004;16:1\u201313.","journal-title":"Neurobiol Dis"},{"key":"3352_CR32","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.2174\/138161212802002706","volume":"18","author":"S Liu","year":"2012","unstructured":"Liu S, Agalliu D, Yu C, Fisher M. The role of pericytes in Blood-Brain barrier function and stroke. Curr Pharm Des. 2012;18:3653\u201362.","journal-title":"Curr Pharm Des"},{"key":"3352_CR33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik A, Genov\u00e9 G, M\u00e4e M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, et al. Pericytes regulate the blood\u2013brain barrier. Nature. 2010;468:557\u201361.","journal-title":"Nature"},{"key":"3352_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.biomaterials.2018.07.014","volume":"180","author":"M Campisi","year":"2018","unstructured":"Campisi M, Shin Y, Osaki T, Hajal C, Chiono V, Kamm RD. 3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes. Biomaterials. 2018;180:117\u201329.","journal-title":"Biomaterials"},{"key":"3352_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00441-016-2397-7","volume":"365","author":"K Zobel","year":"2016","unstructured":"Zobel K, Hansen U, Galla H-J. Blood-brain barrier properties in vitro depend on composition and assembly of endogenous extracellular matrices. Cell Tissue Res. 2016;365:233\u201345.","journal-title":"Cell Tissue Res"},{"key":"3352_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neuint.2008.12.002","volume":"54","author":"S Nakagawa","year":"2009","unstructured":"Nakagawa S, Deli MA, Kawaguchi H, Shimizudani T, Shimono T, Kittel \u00c1, Tanaka K, Niwa M. A new blood\u2013brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int. 2009;54:253\u201363.","journal-title":"Neurochem Int"},{"key":"3352_CR37","doi-asserted-by":"publisher","first-page":"e034225","DOI":"10.1161\/JAHA.124.034225","volume":"13","author":"DC Hergert","year":"2024","unstructured":"Hergert DC, Gaasedelen O, Ryman SG, Prestopnik J, Caprihan A, Rosenberg GA. Blood-Brain barrier permeability is associated with cognitive functioning in normal aging and neurodegenerative diseases. J Am Heart Assoc. 2024;13:e034225.","journal-title":"J Am Heart Assoc"},{"key":"3352_CR38","doi-asserted-by":"publisher","first-page":"7544","DOI":"10.1021\/acs.jmedchem.1c00234","volume":"64","author":"G-L Xiong","year":"2021","unstructured":"Xiong G-L, Zhao Y, Liu L, Ma Z-Y, Lu A-P, Cheng Y, Hou T-J, Cao D-S. Computational bioactivity fingerprint similarities to navigate the discovery of novel scaffolds. J Med Chem. 2021;64:7544\u201354.","journal-title":"J Med Chem"},{"key":"3352_CR39","doi-asserted-by":"publisher","first-page":"147937","DOI":"10.1016\/j.brainres.2022.147937","volume":"1788","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Gan L, Ren L, Lin Y, Ma C, Lin X. Factors influencing the blood-brain barrier permeability. Brain Res. 2022;1788:147937.","journal-title":"Brain Res"},{"key":"3352_CR40","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41586-024-08260-9","volume":"636","author":"K Kang","year":"2024","unstructured":"Kang K, Seidlitz J, Bethlehem RAI, Xiong J, Jones MT, Mehta K, Keller AS, Tao R, Randolph A, Larsen B, et al. Study design features increase replicability in brain-wide association studies. Nature. 2024;636:719\u201327.","journal-title":"Nature"},{"key":"3352_CR41","doi-asserted-by":"publisher","first-page":"e2101090","DOI":"10.1002\/advs.202101090","volume":"8","author":"J Li","year":"2021","unstructured":"Li J, Zheng M, Shimoni O, Banks WA, Bush AI, Gamble JR, Shi B. Development of novel therapeutics targeting the Blood-Brain barrier: from barrier to carrier. Adv Sci (Weinh). 2021;8:e2101090.","journal-title":"Adv Sci (Weinh)"},{"key":"3352_CR42","doi-asserted-by":"crossref","unstructured":"Ou A, Wang Y, Zhang J, Huang Y. Living Cells and Cell-Derived Vesicles: A Trojan Horse Technique for Brain Delivery. Pharmaceutics 2023;15.","DOI":"10.3390\/pharmaceutics15041257"},{"key":"3352_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13321-022-00619-2","volume":"14","author":"X Tong","year":"2022","unstructured":"Tong X, Wang D, Ding X, Tan X, Ren Q, Chen G, Rong Y, Xu T, Huang J, Jiang H, et al. Blood\u2013brain barrier penetration prediction enhanced by uncertainty Estimation. J Cheminform. 2022;14:44.","journal-title":"J Cheminform"},{"key":"3352_CR44","doi-asserted-by":"publisher","first-page":"e1792","DOI":"10.1002\/wnan.1792","volume":"14","author":"R Prasad","year":"2022","unstructured":"Prasad R, Conde J. Bioinspired soft nanovesicles for site-selective cancer imaging and targeted therapies. WIREs Nanomed Nanobiotechnol. 2022;14:e1792.","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"3352_CR45","doi-asserted-by":"publisher","first-page":"e3002112","DOI":"10.1371\/journal.pbio.3002112","volume":"21","author":"Q Huang","year":"2023","unstructured":"Huang Q, Chen AT, Chan KY, Sorensen H, Barry AJ, Azari B, Zheng Q, Beddow T, Zhao B, Tobey IG, et al. Targeting AAV vectors to the central nervous system by engineering capsid-receptor interactions that enable crossing of the blood-brain barrier. PLoS Biol. 2023;21:e3002112.","journal-title":"PLoS Biol"},{"key":"3352_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41568-022-00444-7","volume":"22","author":"S Mehta","year":"2022","unstructured":"Mehta S, Zhang J. Liquid-liquid phase separation drives cellular function and dysfunction in cancer. Nat Rev Cancer. 2022;22:239\u201352.","journal-title":"Nat Rev Cancer"},{"key":"3352_CR47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","volume":"36","author":"NJ Abbott","year":"2013","unstructured":"Abbott NJ. Blood\u2013brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis. 2013;36:437\u201349.","journal-title":"J Inherit Metab Dis"},{"key":"3352_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1517\/17425240902758188","volume":"6","author":"TM Barchet","year":"2009","unstructured":"Barchet TM, Amiji MM. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases. Expert Opin Drug Deliv. 2009;6:211\u201325.","journal-title":"Expert Opin Drug Deliv"},{"key":"3352_CR49","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jconrel.2020.11.021","volume":"330","author":"A Akhtar","year":"2021","unstructured":"Akhtar A, Andleeb A, Waris TS, Bazzar M, Moradi A-R, Awan NR, Yar M. Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics. J Control Release. 2021;330:1152\u201367.","journal-title":"J Control Release"},{"key":"3352_CR50","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.addr.2019.05.003","volume":"148","author":"CL Nemeth","year":"2019","unstructured":"Nemeth CL, Fine AS, Fatemi A. Translational challenges in advancing regenerative therapy for treating neurological disorders using nanotechnology. Adv Drug Deliv Rev. 2019;148:60\u20137.","journal-title":"Adv Drug Deliv Rev"},{"key":"3352_CR51","doi-asserted-by":"publisher","first-page":"104756","DOI":"10.1016\/j.jddst.2023.104756","volume":"86","author":"M Raghav","year":"2023","unstructured":"Raghav M, Gupta V, Awasthi R, Singh A, Kulkarni GT. Nose-to-brain drug delivery: challenges and progress towards brain targeting in the treatment of neurological disorders. J Drug Deliv Sci Technol. 2023;86:104756.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3352_CR52","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2174\/1570159X18666200807143526","volume":"19","author":"V Patel","year":"2021","unstructured":"Patel V, Chavda V, Shah J. Nanotherapeutics in neuropathologies: obstacles, challenges and recent advancements in CNS targeted drug delivery systems. Curr Neuropharmacol. 2021;19:693\u2013710.","journal-title":"Curr Neuropharmacol"},{"key":"3352_CR53","doi-asserted-by":"publisher","first-page":"104955","DOI":"10.1016\/j.neuint.2021.104955","volume":"144","author":"SA Muhammad","year":"2021","unstructured":"Muhammad SA. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders? Neurochem Int. 2021;144:104955.","journal-title":"Neurochem Int"},{"key":"3352_CR54","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.7150\/thno.69682","volume":"12","author":"DH Upton","year":"2022","unstructured":"Upton DH, Ung C, George SM, Tsoli M, Kavallaris M, Ziegler DS. Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy. Theranostics. 2022;12:4734\u201352.","journal-title":"Theranostics"},{"key":"3352_CR55","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/pharmaceutics13010122","volume":"13","author":"RO Elliott","year":"2021","unstructured":"Elliott RO, He M. Unlocking the power of exosomes for crossing biological barriers in drug delivery. Pharmaceutics. 2021;13:122.","journal-title":"Pharmaceutics"},{"key":"3352_CR56","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","volume":"32","author":"T Yang","year":"2015","unstructured":"Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, Yin VP, Lockman P, Bai S. Exosome delivered anticancer drugs across the Blood-Brain barrier for brain cancer therapy in Danio rerio. Pharm Res. 2015;32:2003\u201314.","journal-title":"Pharm Res"},{"key":"3352_CR57","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJA. Delivery of SiRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29:341\u20135.","journal-title":"Nat Biotechnol"},{"key":"3352_CR58","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1007\/s12035-023-03365-0","volume":"60","author":"SH Khatami","year":"2023","unstructured":"Khatami SH, Karami N, Taheri-Anganeh M, Taghvimi S, Tondro G, Khorsand M, Soltani Fard E, Sedighimehr N, Kazemi M, Rahimi Jaberi K, et al. Exosomes: promising delivery tools for overcoming Blood-Brain barrier and glioblastoma therapy. Mol Neurobiol. 2023;60:4659\u201378.","journal-title":"Mol Neurobiol"},{"key":"3352_CR59","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13578-021-00650-0","volume":"11","author":"M Heidarzadeh","year":"2021","unstructured":"Heidarzadeh M, G\u00fcrsoy-\u00d6zdemir Y, Kaya M, Eslami Abriz A, Zarebkohan A, Rahbarghazi R, Sokullu E. Exosomal delivery of therapeutic modulators through the blood\u2013brain barrier; promise and pitfalls. Cell Biosci. 2021;11:142.","journal-title":"Cell Biosci"},{"key":"3352_CR60","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/pharmaceutics14030672","volume":"14","author":"H Choi","year":"2022","unstructured":"Choi H, Choi K, Kim D-H, Oh B-K, Yim H, Jo S, Choi C. Strategies for targeted delivery of exosomes to the brain: advantages and challenges. Pharmaceutics. 2022;14:672.","journal-title":"Pharmaceutics"},{"key":"3352_CR61","doi-asserted-by":"publisher","first-page":"102523","DOI":"10.1016\/j.nano.2022.102523","volume":"41","author":"X Liu","year":"2022","unstructured":"Liu X, Xia T, Fang Y, Zuo H, Dong X, Xu P, Ouyang J. Overcoming the blood\u2013brain barrier by using a multistage exosome delivery system to inhibit central nervous system lymphoma. Nanomedicine. 2022;41:102523.","journal-title":"Nanomedicine"},{"key":"3352_CR62","doi-asserted-by":"publisher","first-page":"420","DOI":"10.22141\/2224-0551.17.8.2022.1550","volume":"17","author":"AE Abaturov","year":"2023","unstructured":"Abaturov AE, Bab\u0443ch VL. Mechanisms of action of extracellular MiRNAs. Child Health. 2023;17:420\u20135.","journal-title":"Child Health"},{"key":"3352_CR63","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/ph16040571","volume":"16","author":"M Abdelsalam","year":"2023","unstructured":"Abdelsalam M, Ahmed M, Osaid Z, Hamoudi R, Harati R. Insights into exosome transport through the blood\u2013brain barrier and the potential therapeutical applications in brain diseases. Pharmaceuticals. 2023;16:571.","journal-title":"Pharmaceuticals"},{"key":"3352_CR64","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.3390\/ijms21124407","volume":"21","author":"WA Banks","year":"2020","unstructured":"Banks WA, Sharma P, Bullock KM, Hansen KM, Ludwig N, Whiteside TL. Transport of extracellular vesicles across the blood-brain barrier: brain pharmacokinetics and effects of inflammation. Int J Mol Sci. 2020;21:4407.","journal-title":"Int J Mol Sci"},{"key":"3352_CR65","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.2174\/1381612823666170913164738","volume":"23","author":"J Matsumoto","year":"2017","unstructured":"Matsumoto J, Stewart T, Banks WA, Zhang J. The transport mechanism of extracellular vesicles at the blood-brain barrier. Curr Pharm Des. 2017;23:6206\u201314.","journal-title":"Curr Pharm Des"},{"key":"3352_CR66","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/cr.2017.71","volume":"27","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Zlokovic BV. Remote control of BBB: A Tale of exosomes and MicroRNA. Cell Res. 2017;27:849\u201350.","journal-title":"Cell Res"},{"key":"3352_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-021-00650-0","volume":"11","author":"M Heidarzadeh","year":"2021","unstructured":"Heidarzadeh M, G\u00fcrsoy-\u00d6zdemir Y, Kaya M, Eslami Abriz A, Zarebkohan A, Rahbarghazi R, Sokullu E. Exosomal delivery of therapeutic modulators through the blood\u2013brain barrier; promise and pitfalls. Cell Biosci. 2021;11:1\u201328.","journal-title":"Cell Biosci"},{"key":"3352_CR68","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12987-022-00359-3","volume":"19","author":"HM Ramos-Zald\u00edvar","year":"2022","unstructured":"Ramos-Zald\u00edvar HM, Polakovicova I, Salas-Huenuleo E, Corval\u00e1n AH, Kogan MJ, Yefi CP, Andia ME. Extracellular vesicles through the blood\u2013brain barrier: A review. Fluids Barriers CNS. 2022;19:60.","journal-title":"Fluids Barriers CNS"},{"key":"3352_CR69","doi-asserted-by":"publisher","first-page":"855017","DOI":"10.3389\/fddev.2022.855017","volume":"2","author":"JP Dardet","year":"2022","unstructured":"Dardet JP, Serrano N, Andr\u00e1s IE, Toborek M. Overcoming blood-brain barrier resistance: implications for extracellular vesicle-mediated drug brain delivery. Front Drug Deliv. 2022;2:855017.","journal-title":"Front Drug Deliv"},{"key":"3352_CR70","doi-asserted-by":"publisher","first-page":"13853","DOI":"10.1021\/acsnano.9b04397","volume":"13","author":"G Morad","year":"2019","unstructured":"Morad G, Carman CV, Hagedorn EJ, Perlin JR, Zon LI, Mustafaoglu N, Park T-E, Ingber DE, Daisy CC, Moses MA. Tumor-derived extracellular vesicles breach the intact blood\u2013brain barrier via transcytosis. ACS Nano. 2019;13:13853\u201365.","journal-title":"ACS Nano"},{"key":"3352_CR71","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1248\/cpb.c19-00854","volume":"68","author":"T Tashima","year":"2020","unstructured":"Tashima T. Smart strategies for therapeutic agent delivery into brain across the blood\u2013brain barrier using receptor-mediated transcytosis. Chem Pharm Bull. 2020;68:316\u201325.","journal-title":"Chem Pharm Bull"},{"key":"3352_CR72","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00018-018-2982-x","volume":"76","author":"R Villase\u00f1or","year":"2019","unstructured":"Villase\u00f1or R, Lampe J, Schwaninger M, Collin L. Intracellular transport and regulation of transcytosis across the blood\u2013brain barrier. Cell Mol Life Sci. 2019;76:1081\u201392.","journal-title":"Cell Mol Life Sci"},{"key":"3352_CR73","doi-asserted-by":"publisher","first-page":"N10","DOI":"10.1227\/NEU.0000000000001242","volume":"78","author":"C Choy","year":"2016","unstructured":"Choy C, Jandial R. Breast cancer exosomes breach the blood-brain barrier. Neurosurgery. 2016;78:N10\u20131.","journal-title":"Neurosurgery"},{"key":"3352_CR74","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/ijms22042193","volume":"22","author":"ZY Soe","year":"2021","unstructured":"Soe ZY, Park EJ, Shimaoka M. Integrin regulation in immunological and cancerous cells and exosomes. Int J Mol Sci. 2021;22:2193.","journal-title":"Int J Mol Sci"},{"key":"3352_CR75","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.3390\/cancers15092504","volume":"15","author":"S Modvig","year":"2023","unstructured":"Modvig S, Jeyakumar J, Marquart HV, Christensen C. Integrins and the metastasis-like dissemination of acute lymphoblastic leukemia to the central nervous system. Cancers. 2023;15:2504.","journal-title":"Cancers"},{"key":"3352_CR76","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3389\/fnins.2019.00569","volume":"13","author":"C Cheyuo","year":"2019","unstructured":"Cheyuo C, Aziz M, Wang P. Neurogenesis in neurodegenerative diseases: role of MFG-E8. Front Neurosci. 2019;13:569.","journal-title":"Front Neurosci"},{"key":"3352_CR77","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1021\/acsnano.2c10219","volume":"17","author":"J Cui","year":"2023","unstructured":"Cui J, Wang X, Li J, Zhu A, Du Y, Zeng W, Guo Y, Di L, Wang R. Immune exosomes loading self-assembled nanomicelles traverse the blood\u2013brain barrier for chemo-immunotherapy against glioblastoma. ACS Nano. 2023;17:1464\u201384.","journal-title":"ACS Nano"},{"key":"3352_CR78","doi-asserted-by":"publisher","first-page":"121567","DOI":"10.1016\/j.biomaterials.2022.121567","volume":"286","author":"N Chen","year":"2022","unstructured":"Chen N, He Y, Zang M, Zhang Y, Lu H, Zhao Q, Wang S, Gao Y. Approaches and materials for endocytosis-independent intracellular delivery of proteins. Biomaterials. 2022;286:121567.","journal-title":"Biomaterials"},{"key":"3352_CR79","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s40135-017-0153-0","volume":"5","author":"Y van der Merwe","year":"2017","unstructured":"van der Merwe Y, Steketee MB. Extracellular vesicles: biomarkers, therapeutics, and vehicles in the visual system. Curr Ophthalmol Rep. 2017;5:276\u201382.","journal-title":"Curr Ophthalmol Rep"},{"key":"3352_CR80","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1146\/annurev-pharmtox-010814-124852","volume":"55","author":"JM Lajoie","year":"2015","unstructured":"Lajoie JM, Shusta EV. Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier. Annu Rev Pharmacol Toxicol. 2015;55:613\u201331.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3352_CR81","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cytogfr.2023.07.007","volume":"73","author":"L Li","year":"2023","unstructured":"Li L, Wang C, Li Q, Guan Y, Zhang X, Kong F, Feng Z, Lu Y, Wang D, Wang N. Exosomes as a modulator of immune resistance in human cancers. Cytokine Growth Factor Rev. 2023;73:135\u201349.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3352_CR82","doi-asserted-by":"crossref","unstructured":"Tian MM, Gabathuler R. The use of peptide and protein vectors to cross the Blood-Brain barrier for the delivery of therapeutic concentration of biologics. Nanomed Brain Drug Deliv 2021:119\u201347.","DOI":"10.1007\/978-1-0716-0838-8_5"},{"key":"3352_CR83","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1007\/s10072-023-06706-y","volume":"44","author":"M Abrishamdar","year":"2023","unstructured":"Abrishamdar M, Jalali MS, Yazdanfar N. The role of exosomes in pathogenesis and the therapeutic efficacy of mesenchymal stem cell-derived exosomes against Parkinson\u2019s disease. Neurol Sci. 2023;44:2277\u201389.","journal-title":"Neurol Sci"},{"key":"3352_CR84","doi-asserted-by":"publisher","first-page":"21933","DOI":"10.1038\/srep21933","volume":"6","author":"YT Sato","year":"2016","unstructured":"Sato YT, Umezaki K, Sawada S, Mukai S-a, Sasaki Y, Harada N, Shiku H, Akiyoshi K. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep. 2016;6:21933.","journal-title":"Sci Rep"},{"key":"3352_CR85","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.gendis.2022.03.021","volume":"10","author":"M Xu","year":"2023","unstructured":"Xu M, Ji J, Jin D, Wu Y, Wu T, Lin R, Zhu S, Jiang F, Ji Y, Bao B. The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): intercellular shuttles and implications in human diseases. Genes Dis. 2023;10:1894\u2013907.","journal-title":"Genes Dis"},{"key":"3352_CR86","doi-asserted-by":"publisher","first-page":"1198044","DOI":"10.3389\/fmolb.2023.1198044","volume":"10","author":"S Ghadami","year":"2023","unstructured":"Ghadami S, Dellinger K. The lipid composition of extracellular vesicles: applications in diagnostics and therapeutic delivery. Front Mol Biosci. 2023;10:1198044.","journal-title":"Front Mol Biosci"},{"key":"3352_CR87","doi-asserted-by":"publisher","first-page":"8278","DOI":"10.1038\/s41598-019-44569-6","volume":"9","author":"M Khongkow","year":"2019","unstructured":"Khongkow M, Yata T, Boonrungsiman S, Ruktanonchai UR, Graham D, Namdee K. Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood\u2013brain barrier penetration. Sci Rep. 2019;9:8278.","journal-title":"Sci Rep"},{"key":"3352_CR88","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.biomaterials.2018.06.029","volume":"178","author":"G Jia","year":"2018","unstructured":"Jia G, Han Y, An Y, Ding Y, He C, Wang X, Tang Q. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials. 2018;178:302\u201316.","journal-title":"Biomaterials"},{"key":"3352_CR89","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1002\/cbic.202100359","volume":"22","author":"L Duan","year":"2021","unstructured":"Duan L, Ouyang K, Wang J, Xu L, Xu X, Wen C, Xie Y, Liang Y, Xia J. Exosomes as targeted delivery platform of CRISPR\/Cas9 for therapeutic genome editing. ChemBioChem. 2021;22:3360\u20138.","journal-title":"ChemBioChem"},{"key":"3352_CR90","doi-asserted-by":"publisher","first-page":"104337","DOI":"10.1016\/j.jddst.2023.104337","volume":"82","author":"K Si","year":"2023","unstructured":"Si K, Ye Z, Ali DJ, Ding B, He C, Dai Z, Li Z, Sun B, Shen Y, Xiao Z. Co-delivery of PDL1-blocking ScFv and chemotherapeutics using engineered exosomes for cancer therapy. J Drug Deliv Sci Technol. 2023;82:104337.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3352_CR91","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/jnc.15288","volume":"157","author":"JR Pinnell","year":"2021","unstructured":"Pinnell JR, Cui M, Tieu K. Exosomes in Parkinson disease. J Neurochem. 2021;157:413\u201328.","journal-title":"J Neurochem"},{"key":"3352_CR92","doi-asserted-by":"publisher","first-page":"2105451","DOI":"10.1002\/advs.202105451","volume":"9","author":"B Li","year":"2022","unstructured":"Li B, Chen X, Qiu W, Zhao R, Duan J, Zhang S, Pan Z, Zhao S, Guo Q, Qi Y. Synchronous disintegration of ferroptosis defense axis via engineered exosome-conjugated magnetic nanoparticles for glioblastoma therapy. Adv Sci. 2022;9:2105451.","journal-title":"Adv Sci"},{"key":"3352_CR93","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jconrel.2023.11.033","volume":"365","author":"R Wang","year":"2024","unstructured":"Wang R, Wang X, Zhao H, Li N, Li J, Zhang H, Di L. Targeted delivery of hybrid nanovesicles for enhanced brain penetration to achieve synergistic therapy of glioma. J Control Release. 2024;365:331\u201347.","journal-title":"J Control Release"},{"key":"3352_CR94","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jconrel.2016.01.009","volume":"224","author":"S Kooijmans","year":"2016","unstructured":"Kooijmans S, Fliervoet L, Van Der Meel R, Fens M, Heijnen H, en, Henegouwen PB, Vader P, Schiffelers R. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J Control Release. 2016;224:77\u201385.","journal-title":"J Control Release"},{"key":"3352_CR95","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12010-022-04090-5","volume":"195","author":"X He","year":"2023","unstructured":"He X, Zhang C, Amirsaadat S, Jalil AT, Kadhim MM, Abasi M, Pilehvar Y. Curcumin-loaded mesenchymal stem cell\u2013derived exosomes efficiently attenuate proliferation and inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. Appl Biochem Biotechnol. 2023;195:51\u201367.","journal-title":"Appl Biochem Biotechnol"},{"key":"3352_CR96","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jconrel.2022.05.027","volume":"347","author":"I Kimiz-Gebologlu","year":"2022","unstructured":"Kimiz-Gebologlu I, Oncel SS. Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake. J Control Release. 2022;347:533\u201343.","journal-title":"J Control Release"},{"key":"3352_CR97","first-page":"61","volume":"76","author":"X-M Xi","year":"2021","unstructured":"Xi X-M, Xia S-J, Lu R. Drug loading techniques for exosome-based drug delivery systems. Pharmazie. 2021;76:61\u20137.","journal-title":"Pharmazie"},{"key":"3352_CR98","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3390\/cells12101416","volume":"12","author":"H Zeng","year":"2023","unstructured":"Zeng H, Guo S, Ren X, Wu Z, Liu S, Yao X. Current strategies for exosome cargo loading and targeting delivery. Cells. 2023;12:1416.","journal-title":"Cells"},{"key":"3352_CR99","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1208\/s12249-023-02624-6","volume":"24","author":"DN Kumar","year":"2023","unstructured":"Kumar DN, Chaudhuri A, Kumar D, Singh S, Agrawal AK. Impact of the drug loading method on the drug distribution and biological efficacy of exosomes. AAPS PharmSciTech. 2023;24:166.","journal-title":"AAPS PharmSciTech"},{"key":"3352_CR100","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s40199-019-00280-5","volume":"27","author":"S Salarpour","year":"2019","unstructured":"Salarpour S, Forootanfar H, Pournamdari M, Ahmadi-Zeidabadi M, Esmaeeli M, Pardakhty A. Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques. DARU J Pharm Sci. 2019;27:533\u20139.","journal-title":"DARU J Pharm Sci"},{"key":"3352_CR101","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jconrel.2020.10.020","volume":"329","author":"J Wang","year":"2021","unstructured":"Wang J, Chen D, Ho EA. Challenges in the development and establishment of exosome-based drug delivery systems. J Control Release. 2021;329:894\u2013906.","journal-title":"J Control Release"},{"key":"3352_CR102","doi-asserted-by":"crossref","unstructured":"Kanchanapally R, Deshmukh SK, Chavva SR, Tyagi N, Srivastava SK, Patel GK, Singh AP, Singh S. Drug-loaded Exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis. Int J Nanomed. 2019;14:531\u201341.","DOI":"10.2147\/IJN.S191313"},{"key":"3352_CR103","doi-asserted-by":"crossref","unstructured":"Tian J, Han Z, Song D, Peng Y, Xiong M, Chen Z, Duan S, Zhang L. Engineered exosome for drug delivery: recent development and clinical applications. Int J Nanomed. 2023;18:7923\u201340.","DOI":"10.2147\/IJN.S444582"},{"key":"3352_CR104","doi-asserted-by":"crossref","unstructured":"Briones-M\u00e1rquez LF, Navarro-Partida J, Herrera-Gonz\u00e1lez A, Garc\u00eda-Bon MA, Mart\u00ednez-\u00c1lvarez IA, Uribe-Rodr\u00edguez D, Gonz\u00e1lez-Ortiz LJ, L\u00f3pez-Naranjo EJ. HPLC-UV evaluation of a microwave assisted method as an active drug loading technique for exosome-based drug delivery system. Heliyon 2023;9:e20742.","DOI":"10.1016\/j.heliyon.2023.e20742"},{"key":"3352_CR105","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41378-022-00374-2","volume":"8","author":"Z Wang","year":"2022","unstructured":"Wang Z, Rich J, Hao N, Gu Y, Chen C, Yang S, Zhang P, Huang TJ. Acoustofluidics for simultaneous nanoparticle-based drug loading and exosome encapsulation. Microsyst Nanoeng. 2022;8:45.","journal-title":"Microsyst Nanoeng"},{"key":"3352_CR106","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jconrel.2022.12.027","volume":"353","author":"J Mondal","year":"2023","unstructured":"Mondal J, Pillarisetti S, Junnuthula V, Saha M, Hwang SR, Park I-k. Lee Y-k: hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications. J Control Release. 2023;353:1127\u201349.","journal-title":"J Control Release"},{"key":"3352_CR107","doi-asserted-by":"publisher","first-page":"586130","DOI":"10.3389\/fbioe.2020.586130","volume":"8","author":"M Xu","year":"2020","unstructured":"Xu M, Yang Q, Sun X, Wang Y. Recent advancements in the loading and modification of therapeutic exosomes. Front Bioeng Biotechnol. 2020;8:586130.","journal-title":"Front Bioeng Biotechnol"},{"key":"3352_CR108","doi-asserted-by":"publisher","first-page":"100261","DOI":"10.1016\/j.impact.2020.100261","volume":"20","author":"S Fu","year":"2020","unstructured":"Fu S, Wang Y, Xia X, Zheng JC. Exosome engineering: current progress in cargo loading and targeted delivery. NanoImpact. 2020;20:100261.","journal-title":"NanoImpact"},{"key":"3352_CR109","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.3390\/pharmaceutics15082042","volume":"15","author":"HB Koh","year":"2023","unstructured":"Koh HB, Kim HJ, Kang S-W, Yoo T-H. Exosome-based drug delivery: translation from bench to clinic. Pharmaceutics. 2023;15:2042.","journal-title":"Pharmaceutics"},{"key":"3352_CR110","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","volume":"11","author":"Y Liang","year":"2021","unstructured":"Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11:3183\u201395.","journal-title":"Theranostics"},{"key":"3352_CR111","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/1061186X.2019.1641508","volume":"28","author":"Y Lin","year":"2020","unstructured":"Lin Y, Lu Y, Li X. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents. J Drug Target. 2020;28:129\u201341.","journal-title":"J Drug Target"},{"key":"3352_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-019-03545-4","volume":"459","author":"A Familtseva","year":"2019","unstructured":"Familtseva A, Jeremic N, Tyagi SC. Exosomes: cell-created drug delivery systems. Mol Cell Biochem. 2019;459:1\u20136.","journal-title":"Mol Cell Biochem"},{"key":"3352_CR113","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/pharmaceutics13040492","volume":"13","author":"CA Ren\u00e9","year":"2021","unstructured":"Ren\u00e9 CA, Parks RJ. Delivery of therapeutic agents to the central nervous system and the promise of extracellular vesicles. Pharmaceutics. 2021;13:492.","journal-title":"Pharmaceutics"},{"key":"3352_CR114","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.biomaterials.2017.10.012","volume":"150","author":"T Tian","year":"2018","unstructured":"Tian T, Zhang H-X, He C-P, Fan S, Zhu Y-L, Qi C, Huang N-P, Xiao Z-D, Lu Z-H, Tannous BA, Gao J. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018;150:137\u201349.","journal-title":"Biomaterials"},{"key":"3352_CR115","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1016\/j.apsb.2023.03.023","volume":"13","author":"TGN Cao","year":"2023","unstructured":"Cao TGN, Kang JH, Kang SJ, Hoang QT, Kang HC, Rhee WJ, Zhang YS, Ko YT, Shim MS. Brain endothelial cell-derived extracellular vesicles with a mitochondria-targeting photosensitizer effectively treat glioblastoma by hijacking the blood-brain barrier. Acta Pharm Sin B. 2023;13:3834\u201348.","journal-title":"Acta Pharm Sin B"},{"key":"3352_CR116","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.7150\/thno.70951","volume":"12","author":"D Peng","year":"2022","unstructured":"Peng D, Wang Y, Xiao Y, Peng M, Mai W, Hu B, Jia Y, Chen H, Yang Y, Xiang Q. Extracellular vesicles derived from astrocyte-treated with haFGF14-154 attenuate alzheimer phenotype in AD mice. Theranostics. 2022;12:3862.","journal-title":"Theranostics"},{"key":"3352_CR117","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40035-023-00372-y","volume":"12","author":"P Wang","year":"2023","unstructured":"Wang P, Lan G, Xu B, Yu Z, Tian C, Lei X, Meissner WG, Feng T, Yang Y, Zhang J. \u03b1-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis. Transl Neurodegener. 2023;12:40.","journal-title":"Transl Neurodegener"},{"key":"3352_CR118","doi-asserted-by":"crossref","unstructured":"Zhu Y, Wang F, Xia Y, Wang L, Lin H, Zhong T, Wang X. Research progress on astrocyte-derived extracellular vesicles in the pathogenesis and treatment of neurodegenerative diseases. Rev Neurosci. 2024;35:855\u201375.","DOI":"10.1515\/revneuro-2024-0043"},{"key":"3352_CR119","doi-asserted-by":"publisher","first-page":"114258","DOI":"10.1016\/j.colsurfb.2024.114258","volume":"245","author":"Y Liu","year":"2025","unstructured":"Liu Y, Li M, Gu J, Huang H, Xie H, Yu C, Roy S, Chen X, Kuang T, Zhang Y. Engineering of exosome-liposome hybrid-based theranostic nanomedicines for NIR-II fluorescence imaging-guided and targeted NIR-II photothermal therapy of subcutaneous glioblastoma. Colloids Surf B Biointerfaces. 2025;245:114258.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3352_CR120","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L. Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther. 2024;9:211.","journal-title":"Signal Transduct Target Ther"},{"key":"3352_CR121","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fnins.2020.00564","volume":"14","author":"Y Jahangard","year":"2020","unstructured":"Jahangard Y, Monfared H, Moradi A, Zare M, Mirnajafi-Zadeh J, Mowla SJ. Therapeutic effects of transplanted exosomes containing miR-29b to a rat model of Alzheimer\u2019s disease. Front Neurosci. 2020;14:564.","journal-title":"Front Neurosci"},{"key":"3352_CR122","doi-asserted-by":"publisher","first-page":"1906273","DOI":"10.1002\/smll.201906273","volume":"16","author":"L Yang","year":"2020","unstructured":"Yang L, Zhai Y, Hao Y, Zhu Z, Cheng G. The regulatory functionality of exosomes derived from hUMSCs in 3D culture for Alzheimer\u2019s disease therapy. Small. 2020;16:1906273.","journal-title":"Small"},{"key":"3352_CR123","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12979-019-0150-2","volume":"16","author":"GH Cui","year":"2019","unstructured":"Cui GH, Guo HD, Li H, Zhai Y, Gong ZB, Wu J, Liu JS, Dong YR, Hou SX, Liu JR. RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer\u2019s disease. Immun Ageing. 2019;16:10.","journal-title":"Immun Ageing"},{"key":"3352_CR124","doi-asserted-by":"publisher","first-page":"7481","DOI":"10.1039\/C9NR01255A","volume":"11","author":"H Wang","year":"2019","unstructured":"Wang H, Sui H, Zheng Y, Jiang Y, Shi Y, Liang J, Zhao L. Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT\/GSK-3\u03b2 pathway. Nanoscale. 2019;11:7481\u201396.","journal-title":"Nanoscale"},{"key":"3352_CR125","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1080\/10717544.2020.1762262","volume":"27","author":"Y Qi","year":"2020","unstructured":"Qi Y, Guo L, Jiang Y, Shi Y, Sui H, Zhao L. Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles. Drug Deliv. 2020;27:745\u201355.","journal-title":"Drug Deliv"},{"key":"3352_CR126","doi-asserted-by":"publisher","first-page":"113224","DOI":"10.1016\/j.biopha.2022.113224","volume":"152","author":"M Sheykhhasan","year":"2022","unstructured":"Sheykhhasan M, Amini R, Soleimani Asl S, Saidijam M, Hashemi SM, Najafi R. Neuroprotective effects of coenzyme Q10-loaded exosomes obtained from adipose-derived stem cells in a rat model of Alzheimer\u2019s disease. Biomed Pharmacother. 2022;152:113224.","journal-title":"Biomed Pharmacother"},{"key":"3352_CR127","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jconrel.2021.06.018","volume":"336","author":"M Fernandes","year":"2021","unstructured":"Fernandes M, Lopes I, Magalh\u00e3es L, S\u00e1rria MP, Machado R, Sousa JC, Botelho C, Teixeira J, Gomes AC. Novel concept of exosome-like liposomes for the treatment of Alzheimer\u2019s disease. J Control Release. 2021;336:130\u201343.","journal-title":"J Control Release"},{"key":"3352_CR128","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1111\/ejn.16541","volume":"60","author":"E Akyuz","year":"2024","unstructured":"Akyuz E, Aslan FS, Gokce E, Ilmaz O, Topcu F, Kakac S. Extracellular vesicle and CRISPR gene therapy: current applications in Alzheimer\u2019s disease, Parkinson\u2019s disease, amyotrophic lateral sclerosis, and Huntington\u2019s disease. Eur J Neurosci. 2024;60:6057\u201390.","journal-title":"Eur J Neurosci"},{"key":"3352_CR129","doi-asserted-by":"publisher","first-page":"eadi4830","DOI":"10.1126\/scitranslmed.adi4830","volume":"16","author":"J Han","year":"2024","unstructured":"Han J, Sul JH, Lee J, Kim E, Kim HK, Chae M, Lim J, Kim J, Kim C, Kim J-S. Engineered exosomes with a photoinducible protein delivery system enable CRISPR-Cas\u2013based epigenome editing in Alzheimer\u2019s disease. Sci Transl Med. 2024;16:eadi4830.","journal-title":"Sci Transl Med"},{"key":"3352_CR130","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","volume":"15","author":"A Elkouzi","year":"2019","unstructured":"Elkouzi A, Vedam-Mai V, Eisinger RS, Okun MS. Emerging therapies in Parkinson disease\u2014repurposed drugs and new approaches. Nat Rev Neurol. 2019;15:204\u201323.","journal-title":"Nat Rev Neurol"},{"key":"3352_CR131","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.ymthe.2019.08.010","volume":"27","author":"M Izco","year":"2019","unstructured":"Izco M, Blesa J, Schleef M, Schmeer M, Porcari R, Al-Shawi R, Ellmerich S, de Toro M, Gardiner C, Seow Y, et al. Systemic Exosomal delivery of ShRNA minicircles prevents parkinsonian pathology. Mol Ther. 2019;27:2111\u201322.","journal-title":"Mol Ther"},{"key":"3352_CR132","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/mds.25978","volume":"29","author":"JM Cooper","year":"2014","unstructured":"Cooper JM, Wiklander PB, Nordin JZ, Al-Shawi R, Wood MJ, Vithlani M, Schapira AH, Simons JP, El-Andaloussi S, Alvarez-Erviti L. Systemic Exosomal SiRNA delivery reduced alpha-synuclein aggregates in brains of Transgenic mice. Mov Disord. 2014;29:1476\u201385.","journal-title":"Mov Disord"},{"key":"3352_CR133","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1021\/acsnano.3c05864","volume":"18","author":"W Kong","year":"2024","unstructured":"Kong W, Li X, Guo X, Sun Y, Chai W, Chang Y, Huang Q, Wang P, Wang X. Ultrasound-Assisted CRISPRi-Exosome for epigenetic modification of \u03b1-Synuclein gene in a mouse model of Parkinson\u2019s disease. ACS Nano. 2024;18:7837\u201351.","journal-title":"ACS Nano"},{"key":"3352_CR134","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","volume":"287","author":"M Qu","year":"2018","unstructured":"Qu M, Lin Q, Huang L, Fu Y, Wang L, He S, Fu Y, Yang S, Zhang Z, Zhang L, Sun X. Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson\u2019s disease. J Control Release. 2018;287:156\u201366.","journal-title":"J Control Release"},{"key":"3352_CR135","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","volume":"9","author":"R Kojima","year":"2018","unstructured":"Kojima R, Bojar D, Rizzi G, Hamri GC-E, El-Baba MD, Saxena P, Ausl\u00e4nder S, Tan KR, Fussenegger M. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment. Nat Commun. 2018;9:1305.","journal-title":"Nat Commun"},{"key":"3352_CR136","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.omtn.2019.07.008","volume":"17","author":"X Ren","year":"2019","unstructured":"Ren X, Zhao Y, Xue F, Zheng Y, Huang H, Wang W, Chang Y, Yang H, Zhang J. Exosomal DNA aptamer targeting \u03b1-Synuclein aggregates reduced neuropathological deficits in a mouse Parkinson\u2019s disease model. Mol Ther Nucleic Acids. 2019;17:726\u201340.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3352_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2024.04.010","volume":"549","author":"W Huang","year":"2024","unstructured":"Huang W, Zhang T, Li X, Gong L, Zhang Y, Luan C, Shan Q, Gu X, Zhao L. Intranasal administration of umbilical cord mesenchymal stem cell exosomes alleviates Parkinson\u2019s disease. Neuroscience. 2024;549:1\u201312.","journal-title":"Neuroscience"},{"key":"3352_CR138","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/ajmg.a.38494","volume":"176","author":"AS Dickey","year":"2018","unstructured":"Dickey AS, La Spada AR. Therapy development in huntington disease: from current strategies to emerging opportunities. Am J Med Genet A. 2018;176:842\u201361.","journal-title":"Am J Med Genet A"},{"key":"3352_CR139","first-page":"A88","volume":"89","author":"T Wu","year":"2018","unstructured":"Wu T, Yu M, Zhang L, Chen X, Pei Z. Systemic injection of Exosomal SiRNA significantly reduced Huntingtin expression in Transgenic mice of Huntington\u2019s disease. J Neurol Neurosurg Psychiatry. 2018;89:A88\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3352_CR140","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/mt.2016.126","volume":"24","author":"MC Didiot","year":"2016","unstructured":"Didiot MC, Hall LM, Coles AH, Haraszti RA, Godinho BM, Chase K, Sapp E, Ly S, Alterman JF, Hassler MR, et al. Exosome-mediated delivery of hydrophobically modified SiRNA for Huntingtin mRNA Silencing. Mol Ther. 2016;24:1836\u201347.","journal-title":"Mol Ther"},{"key":"3352_CR141","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14802\/jmd.16054","volume":"10","author":"ST Lee","year":"2017","unstructured":"Lee ST, Im W, Ban JJ, Lee M, Jung KH, Lee SK, Chu K, Kim M. Exosome-Based delivery of miR-124 in a Huntington\u2019s disease model. J Mov Disord. 2017;10:45\u201352.","journal-title":"J Mov Disord"},{"key":"3352_CR142","doi-asserted-by":"publisher","first-page":"137493","DOI":"10.1016\/j.neulet.2023.137493","volume":"816","author":"T Gschwendtberger","year":"2023","unstructured":"Gschwendtberger T, Thau-Habermann N, von der Ohe J, Luo T, Hass R, Petri S. Protective effects of EVs\/exosomes derived from permanently growing human MSC on primary murine ALS motor neurons. Neurosci Lett. 2023;816:137493.","journal-title":"Neurosci Lett"},{"key":"3352_CR143","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/life12091417","volume":"12","author":"DD Ojeda-Hern\u00e1ndez","year":"2022","unstructured":"Ojeda-Hern\u00e1ndez DD, Hern\u00e1ndez-Sapi\u00e9ns MA, Reza-Zald\u00edvar EE, Canales-Aguirre A, Mat\u00edas-Guiu JA, Mat\u00edas-Guiu J, Mateos-D\u00edaz JC, G\u00f3mez-Pinedo U, Sancho-Bielsa F. Exosomes and biomaterials: in search of a new therapeutic strategy for multiple sclerosis. Life. 2022;12:1417.","journal-title":"Life"},{"key":"3352_CR144","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.3390\/ijms21103651","volume":"21","author":"R Bonafede","year":"2020","unstructured":"Bonafede R, Turano E, Scambi I, Busato A, Bontempi P, Virla F, Schiaffino L, Marzola P, Bonetti B, Mariotti R. ASC-exosomes ameliorate the disease progression in SOD1 (G93A) murine model underlining their potential therapeutic use in human ALS. Int J Mol Sci. 2020;21:3651.","journal-title":"Int J Mol Sci"},{"key":"3352_CR145","doi-asserted-by":"publisher","first-page":"754630","DOI":"10.3389\/fcell.2021.754630","volume":"9","author":"K Wang","year":"2021","unstructured":"Wang K, Li Y, Ren C, Wang Y, He W, Jiang Y. Extracellular vesicles as innovative treatment strategy for amyotrophic lateral sclerosis. Front Cell Dev Biol. 2021;9:754630.","journal-title":"Front Cell Dev Biol"},{"key":"3352_CR146","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4103\/NRR.NRR-D-23-01815","volume":"20","author":"PJ Goldschmidt-Clermont","year":"2025","unstructured":"Goldschmidt-Clermont PJ, Khan A, Jimsheleishvili G, Graham P, Brooks A, Silvera R, Goldschmidt AJ, Pearse DD, Dietrich WD, Levi AD. Treating amyotrophic lateral sclerosis with allogeneic Schwann cell\u2013derived Exosomal vesicles: a case report. Neural Regen Res. 2025;20:1207\u201316.","journal-title":"Neural Regen Res"},{"key":"3352_CR147","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1080\/14712598.2024.2392307","volume":"24","author":"L Mazzini","year":"2024","unstructured":"Mazzini L, De Marchi F, Buzanska L, Follenzi A, Glover JC, Gelati M, Lombardi I, Maioli M, Mesa-Herrera F, Mitre\u010di\u0107 D. Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis. Expert Opin Biol Ther. 2024;24:933\u201354.","journal-title":"Expert Opin Biol Ther"},{"key":"3352_CR148","unstructured":"Ciccone I. FDA Clears Aruna Bio\u2019s Exosome AB126 for Clinical Trials in Neurological Indication. Neurol Live 2024:NA-NA."},{"key":"3352_CR149","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1208\/s12248-016-0015-y","volume":"19","author":"T Yang","year":"2017","unstructured":"Yang T, Fogarty B, LaForge B, Aziz S, Pham T, Lai L, Bai S. Delivery of small interfering RNA to inhibit vascular endothelial growth factor in zebrafish using natural brain endothelia Cell-Secreted exosome nanovesicles for the treatment of brain cancer. AAPS J. 2017;19:475\u201386.","journal-title":"AAPS J"},{"key":"3352_CR150","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jconrel.2019.11.009","volume":"317","author":"G Kim","year":"2020","unstructured":"Kim G, Kim M, Lee Y, Byun JW, Hwang DW, Lee M. Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes. J Control Release. 2020;317:273\u201381.","journal-title":"J Control Release"},{"key":"3352_CR151","doi-asserted-by":"publisher","first-page":"12341","DOI":"10.1021\/acsami.7b18135","volume":"10","author":"Z Ye","year":"2018","unstructured":"Ye Z, Zhang T, He W, Jin H, Liu C, Yang Z, Ren J. Methotrexate-Loaded extracellular vesicles functionalized with therapeutic and targeted peptides for the treatment of glioblastoma multiforme. ACS Appl Mater Interfaces. 2018;10:12341\u201350.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3352_CR152","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.canlet.2013.02.019","volume":"335","author":"M Katakowski","year":"2013","unstructured":"Katakowski M, Buller B, Zheng X, Lu Y, Rogers T, Osobamiro O, Shu W, Jiang F, Chopp M. Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett. 2013;335:201\u20134.","journal-title":"Cancer Lett"},{"key":"3352_CR153","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1038\/mtna.2013.60","volume":"2","author":"JL Munoz","year":"2013","unstructured":"Munoz JL, Bliss SA, Greco SJ, Ramkissoon SH, Ligon KL, Rameshwar P. Delivery of functional Anti-miR-9 by mesenchymal stem Cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol Ther Nucleic Acids. 2013;2:e126.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3352_CR154","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/mt.2012.161","volume":"21","author":"A Mizrak","year":"2013","unstructured":"Mizrak A, Bolukbasi MF, Ozdener GB, Brenner GJ, Madlener S, Erkan EP, Str\u00f6bel T, Breakefield XO, Saydam O. Genetically engineered microvesicles carrying suicide mRNA\/protein inhibit Schwannoma tumor growth. Mol Ther. 2013;21:101\u20138.","journal-title":"Mol Ther"},{"key":"3352_CR155","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/neuonc\/noac071","volume":"24","author":"Q Zhan","year":"2022","unstructured":"Zhan Q, Yi K, Cui X, Li X, Yang S, Wang Q, Fang C, Tan Y, Li L, Xu C. Blood exosomes-based targeted delivery of cPLA2 SiRNA and Metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy. Neuro Oncol. 2022;24:1871\u201383.","journal-title":"Neuro Oncol"},{"key":"3352_CR156","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.canlet.2017.09.022","volume":"411","author":"H Liu","year":"2017","unstructured":"Liu H, Chen L, Liu J, Meng H, Zhang R, Ma L, Wu L, Yu S, Shi F, Li Y. Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma. Cancer Lett. 2017;411:182\u201390.","journal-title":"Cancer Lett"},{"key":"3352_CR157","doi-asserted-by":"publisher","first-page":"120784","DOI":"10.1016\/j.biomaterials.2021.120784","volume":"273","author":"J Wang","year":"2021","unstructured":"Wang J, Tang W, Yang M, Yin Y, Li H, Hu F, Tang L, Ma X, Zhang Y, Wang Y. Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy. Biomaterials. 2021;273:120784.","journal-title":"Biomaterials"},{"key":"3352_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2022.5405","volume":"61","author":"C Qian","year":"2022","unstructured":"Qian C, Wang Y, Ji Y, Chen D, Wang C, Zhang G, Wang Y. Neural stem cell-derived exosomes transfer miR-124-3p into cells to inhibit glioma growth by targeting FLOT2. Int J Oncol. 2022;61:1\u201312.","journal-title":"Int J Oncol"},{"key":"3352_CR159","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.omtn.2021.12.029","volume":"27","author":"T Adamus","year":"2022","unstructured":"Adamus T, Hung C-Y, Yu C, Kang E, Hammad M, Flores L, Nechaev S, Zhang Q, Gonzaga JM, Muthaiyah K. Glioma-targeted delivery of exosome-encapsulated antisense oligonucleotides using neural stem cells. Mol Ther Nucleic Acids. 2022;27:611\u201320.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3352_CR160","doi-asserted-by":"publisher","first-page":"102310","DOI":"10.1016\/j.nantod.2024.102310","volume":"56","author":"Y Sun","year":"2024","unstructured":"Sun Y, Li M, Zheng M, Zou Y, Shi B. Blood-brain barrier penetrating nanosystems enable synergistic therapy of glioblastoma. Nano Today. 2024;56:102310.","journal-title":"Nano Today"},{"key":"3352_CR161","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12943-019-1000-8","volume":"18","author":"L Zhu","year":"2019","unstructured":"Zhu L, Li J, Gong Y, Wu Q, Tan S, Sun D, Xu X, Zuo Y, Zhao Y, Wei Y-Q, et al. Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis. Mol Cancer. 2019;18:74.","journal-title":"Mol Cancer"},{"key":"3352_CR162","doi-asserted-by":"publisher","first-page":"144692","DOI":"10.1016\/j.cej.2023.144692","volume":"471","author":"J Li","year":"2023","unstructured":"Li J, Wang X, Guo Y, Zhang Y, Zhu A, Zeng W, Di L, Wang R. Ginsenoside Rg3-engineered exosomes as effective delivery platform for potentiated chemotherapy and photoimmunotherapy of glioblastoma. Chem Eng J. 2023;471:144692.","journal-title":"Chem Eng J"},{"key":"3352_CR163","doi-asserted-by":"publisher","first-page":"2200353","DOI":"10.1002\/advs.202200353","volume":"9","author":"S Shan","year":"2022","unstructured":"Shan S, Chen J, Sun Y, Wang Y, Xia B, Tan H, Pan C, Gu G, Zhong J, Qing G. Functionalized macrophage exosomes with Panobinostat and PPM1D-siRNA for diffuse intrinsic Pontine gliomas therapy. Adv Sci. 2022;9:2200353.","journal-title":"Adv Sci"},{"key":"3352_CR164","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3389\/fonc.2019.00782","volume":"9","author":"H Monfared","year":"2019","unstructured":"Monfared H, Jahangard Y, Nikkhah M, Mirnajafi-Zadeh J, Mowla SJ. Potential therapeutic effects of exosomes packed with a miR-21-Sponge construct in a rat model of glioblastoma. Front Oncol. 2019;9:782.","journal-title":"Front Oncol"},{"key":"3352_CR165","doi-asserted-by":"publisher","first-page":"13287","DOI":"10.18632\/aging.203013","volume":"13","author":"Y Han","year":"2021","unstructured":"Han Y, Liu Y, Zhang B, Yin G. Exosomal circrna 0001445 promotes glioma progression through miRNA-127-5p\/SNX5 pathway. Aging. 2021;13:13287\u201399.","journal-title":"Aging"},{"key":"3352_CR166","doi-asserted-by":"crossref","unstructured":"Lee Y, Kang S, Son M, Park JY, Ahn SB, Kang M, Oh J, Choi JS, Lee M. Exosome-membrane and polymer-based hybrid-complex for systemic delivery of plasmid DNA into brains for the treatment of glioblastoma. Asian J Pharm Sci. 2024;20:101006.","DOI":"10.1016\/j.ajps.2024.101006"},{"key":"3352_CR167","doi-asserted-by":"publisher","first-page":"16432","DOI":"10.1021\/acsnano.2c12857","volume":"17","author":"X Liu","year":"2023","unstructured":"Liu X, Cao Z, Wang W, Zou C, Wang Y, Pan L, Jia B, Zhang K, Zhang W, Li W, et al. Engineered extracellular Vesicle-Delivered CRISPR\/Cas9 for radiotherapy sensitization of glioblastoma. ACS Nano. 2023;17:16432\u201347.","journal-title":"ACS Nano"},{"key":"3352_CR168","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1161\/01.CIR.0000012747.53592.6A","volume":"105","author":"D Tanne","year":"2002","unstructured":"Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, Levine SR. Group Mr-PSS: markers of increased risk of intracerebral hemorrhage after intravenous Recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the multicenter rt-PA acute stroke survey. Circulation. 2002;105:1679\u201385.","journal-title":"Circulation"},{"key":"3352_CR169","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/bioengineering10020177","volume":"10","author":"S Khalil","year":"2023","unstructured":"Khalil S, Kanapathipillai M. Exosome-coated tPA\/catalase nanoformulation for thrombolytic therapy. Bioengineering. 2023;10:177.","journal-title":"Bioengineering"},{"key":"3352_CR170","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1161\/STROKEAHA.118.023815","volume":"50","author":"M Enomoto","year":"2019","unstructured":"Enomoto M, Endo A, Yatsushige H, Fushimi K, Otomo Y. Clinical effects of early Edaravone use in acute ischemic stroke patients treated by endovascular reperfusion therapy. Stroke. 2019;50:652\u20138.","journal-title":"Stroke"},{"key":"3352_CR171","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1021\/acs.molpharmaceut.0c00245","volume":"17","author":"F Li","year":"2020","unstructured":"Li F, Zhao L, Shi Y, Liang J. Edaravone-loaded macrophage-derived exosomes enhance neuroprotection in the rat permanent middle cerebral artery occlusion model of stroke. Mol Pharm. 2020;17:3192\u2013201.","journal-title":"Mol Pharm"},{"key":"3352_CR172","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1049\/nbt2.12003","volume":"15","author":"L Guo","year":"2021","unstructured":"Guo L, Pan J, Li F, Zhao L, Shi Y. A novel brain targeted plasma exosomes enhance the neuroprotective efficacy of Edaravone in ischemic stroke. IET Nanobiotechnol. 2021;15:107\u201316.","journal-title":"IET Nanobiotechnol"},{"key":"3352_CR173","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/s41551-021-00705-0","volume":"5","author":"S Hu","year":"2021","unstructured":"Hu S, Li Z, Shen D, Zhu D, Huang K, Su T, Dinh P-U, Cores J, Cheng K. Exosome-eluting stents for vascular healing after ischaemic injury. Nat Biomed Eng. 2021;5:1174\u201388.","journal-title":"Nat Biomed Eng"},{"key":"3352_CR174","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.18632\/aging.202466","volume":"13","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zou X, Zhang R, Xie Y, Feng Z, Li F, Han J, Sun H, Ouyang Q, Hua S. Human umbilical cord mesenchymal stem cell-derived Exosomal miR-146a-5p reduces microglial-mediated neuroinflammation via suppression of the IRAK1\/TRAF6 signaling pathway after ischemic stroke. Aging. 2021;13:3060.","journal-title":"Aging"},{"key":"3352_CR175","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.omtn.2017.04.010","volume":"7","author":"J Yang","year":"2017","unstructured":"Yang J, Zhang X, Chen X, Wang L, Yang G. Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia. Mol Ther Nucleic Acids. 2017;7:278\u201387.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3352_CR176","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1166\/jbn.2019.2866","volume":"15","author":"M Kim","year":"2019","unstructured":"Kim M, Kim G, Hwang DW, Lee M. Delivery of high mobility group box-1 SiRNA using brain-targeting exosomes for ischemic stroke therapy. J Biomed Nanotechnol. 2019;15:2401\u201312.","journal-title":"J Biomed Nanotechnol"},{"key":"3352_CR177","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.biomaterials.2017.10.012","volume":"150","author":"T Tian","year":"2018","unstructured":"Tian T, Zhang H-X, He C-P, Fan S, Zhu Y-L, Qi C, Huang N-P, Xiao Z-D, Lu Z-H, Tannous BA. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018;150:137\u201349.","journal-title":"Biomaterials"},{"key":"3352_CR178","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s13346-023-01408-6","volume":"14","author":"X Liu","year":"2024","unstructured":"Liu X, Hao Y, Huang Z, Shi Y, Su C, Zhao L. Modulation of microglial polarization by sequential targeting surface-engineered exosomes improves therapy for ischemic stroke. Drug Deliv Transl Res. 2024;14:418\u201332.","journal-title":"Drug Deliv Transl Res"},{"key":"3352_CR179","doi-asserted-by":"publisher","first-page":"119942","DOI":"10.1016\/j.biomaterials.2020.119942","volume":"243","author":"HY Kim","year":"2020","unstructured":"Kim HY, Kim TJ, Kang L, Kim Y-J, Kang MK, Kim J, Ryu JH, Hyeon T, Yoon B-W, Ko S-B. Mesenchymal stem cell-derived magnetic extracellular nanovesicles for targeting and treatment of ischemic stroke. Biomaterials. 2020;243:119942.","journal-title":"Biomaterials"},{"key":"3352_CR180","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2174\/0118715273288155240201065041","volume":"23","author":"S Ashique","year":"2024","unstructured":"Ashique S, Pal R, Sharma H, Mishra N, Garg A. Unraveling the emerging niche role of extracellular vesicles (EVs) in traumatic brain injury (TBI). CNS Neurol Disord Drug Targets. 2024;23:1357\u201370.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3352_CR181","doi-asserted-by":"publisher","first-page":"18274","DOI":"10.18632\/aging.103692","volume":"12","author":"Y Chen","year":"2020","unstructured":"Chen Y, Li J, Ma B, Li N, Wang S, Sun Z, Xue C, Han Q, Wei J, Zhao RC. MSC-derived exosomes promote recovery from traumatic brain injury via microglia\/macrophages in rat. Aging. 2020;12:18274.","journal-title":"Aging"},{"key":"3352_CR182","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13287-023-03409-1","volume":"14","author":"L Zhong","year":"2023","unstructured":"Zhong L, Wang J, Wang P, Liu X, Liu P, Cheng X, Cao L, Wu H, Chen J, Zhou L. Neural stem cell-derived exosomes and regeneration: cell-free therapeutic strategies for traumatic brain injury. Stem Cell Res Ther. 2023;14:198.","journal-title":"Stem Cell Res Ther"},{"key":"3352_CR183","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s12015-022-10483-0","volume":"19","author":"M Hajinejad","year":"2023","unstructured":"Hajinejad M, Ebrahimzadeh MH, Ebrahimzadeh Bideskan A, Rajabian A, Gorji A, Sahab Negah S. Exosomes and nano-SDF scaffold as a cell-free-based treatment strategy improve traumatic brain injury mechanisms by decreasing oxidative stress, neuroinflammation, and increasing neurogenesis. Stem Cell Rev Rep. 2023;19:1001\u201318.","journal-title":"Stem Cell Rev Rep"},{"key":"3352_CR184","doi-asserted-by":"publisher","first-page":"0402","DOI":"10.34133\/research.0402","volume":"7","author":"S Liu","year":"2024","unstructured":"Liu S, Chen L, Guo M, Li Y, Liu Q, Cheng Y. Targeted delivery of engineered RVG-BDNF-exosomes: a novel Neurobiological approach for ameliorating depression and regulating neurogenesis. Res. 2024;7:0402.","journal-title":"Res"},{"key":"3352_CR185","doi-asserted-by":"publisher","first-page":"28223","DOI":"10.1038\/s41598-024-79558-x","volume":"14","author":"S Huang","year":"2024","unstructured":"Huang S, Nie Y, Qin J, Wen M, Wang Q, Xie F, Song F, Yang B. Hippocampal exosomes from stroke aggravate post-stroke depression by regulating the expression of ProBDNF and p75NTR and altering spine density. Sci Rep. 2024;14:28223.","journal-title":"Sci Rep"},{"key":"3352_CR186","doi-asserted-by":"publisher","first-page":"771898","DOI":"10.3389\/fncel.2021.771898","volume":"15","author":"J Zhao","year":"2021","unstructured":"Zhao J, He Z, Wang J. MicroRNA-124: a key player in microglia-mediated inflammation in neurological diseases. Front Cell Neurosci. 2021;15:771898.","journal-title":"Front Cell Neurosci"},{"key":"3352_CR187","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.ymthe.2021.11.006","volume":"30","author":"C Fan","year":"2022","unstructured":"Fan C, Li Y, Lan T, Wang W, Long Y, Yu SY. Microglia secrete miR-146a-5p-containing exosomes to regulate neurogenesis in depression. Mol Ther. 2022;30:1300\u201314.","journal-title":"Mol Ther"},{"key":"3352_CR188","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","volume":"1793","author":"SU Walkley","year":"2008","unstructured":"Walkley SU, Vanier MT. Pathomechanisms in lysosomal storage disorders. Biochim Biophys Acta. 2008;1793:726.","journal-title":"Biochim Biophys Acta"},{"key":"3352_CR189","unstructured":"Brown A. Characterizing a Gaucher\u2019s Disease Model for the Evaluation of Novel Exosome-Based Enzyme Replacement Therapy. 2020."},{"key":"3352_CR190","doi-asserted-by":"publisher","first-page":"559804","DOI":"10.3389\/fmolb.2020.559804","volume":"7","author":"MJ Edelmann","year":"2020","unstructured":"Edelmann MJ, Maegawa GH. CNS-targeting therapies for lysosomal storage diseases: current advances and challenges. Front Mol Biosci. 2020;7:559804.","journal-title":"Front Mol Biosci"},{"key":"3352_CR191","doi-asserted-by":"crossref","unstructured":"Cho HY, Yoo M, Pongkulapa T, Rabie H, Muotri AR, Yin PT, Choi JW, Lee KB. Magnetic Nanoparticle-Assisted Non-Viral CRISPR-Cas9 for enhanced genome editing to treat Rett syndrome. Adv Sci. 2024;11:2306432.","DOI":"10.1002\/advs.202306432"},{"key":"3352_CR192","unstructured":"Yazdani S. Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke. Isfahan: Isfahan University of Medical Sciences. (ClinicalTrials.gov) 2019."},{"key":"3352_CR193","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3390\/pharmaceutics16121492","volume":"16","author":"J Lee","year":"2024","unstructured":"Lee J, Geum D, Park D-H, Kim J-H. Molecular targeting of ischemic stroke: the promise of Na\u00efve and engineered extracellular vesicles. Pharmaceutics. 2024;16:1492.","journal-title":"Pharmaceutics"},{"key":"3352_CR194","doi-asserted-by":"crossref","unstructured":"Xie X, Song Q, Dai C, Cui S, Tang R, Li S, Chang J, Li P, Wang J, Li J. Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer\u2019s disease: a phase I\/II clinical trial. Gen Psychiatry. 2023;36:e101143.","DOI":"10.1136\/gpsych-2023-101143"},{"key":"3352_CR195","first-page":"55","volume":"2","author":"L Xiao","year":"2021","unstructured":"Xiao L, Hareendran S, Loh YP. Function of exosomes in neurological disorders and brain tumors. Extracell Vesicles Circ Nucleic Acids. 2021;2:55\u201379.","journal-title":"Extracell Vesicles Circ Nucleic Acids"},{"key":"3352_CR196","doi-asserted-by":"publisher","first-page":"118549","DOI":"10.1016\/j.molliq.2022.118549","volume":"350","author":"S Salarpour","year":"2022","unstructured":"Salarpour S, Barani M, Pardakhty A, Khatami M, Pal Singh Chauhan N. The application of exosomes and Exosome-nanoparticle in treating brain disorders. J Mol Liq. 2022;350:118549.","journal-title":"J Mol Liq"},{"key":"3352_CR197","doi-asserted-by":"crossref","unstructured":"Choi H, Choi K, Kim D-H, Oh B-K, Yim H, Jo S, Choi C. Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges. Pharmaceutics 2022, 14.","DOI":"10.3390\/pharmaceutics14030672"},{"key":"3352_CR198","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12967-024-04893-6","volume":"22","author":"H Li","year":"2024","unstructured":"Li H, Yuan Y, Xie Q, Dong Z. Exosomes: potential targets for the diagnosis and treatment of neuropsychiatric disorders. J Transl Med. 2024;22:115.","journal-title":"J Transl Med"},{"key":"3352_CR199","doi-asserted-by":"publisher","first-page":"116920","DOI":"10.1016\/j.trac.2023.116920","volume":"159","author":"FG Ortega-Sanchez","year":"2023","unstructured":"Ortega-Sanchez FG, Teresa V, Widmann T, Regiart M, Jerez-Salcedo MT, Fern\u00e1ndez-Baldo MA, de Miguel-Perez D. Microfluidic systems in extracellular vesicles single analysis. A systematic review. TrAC Trends Anal Chem. 2023;159:116920.","journal-title":"TrAC Trends Anal Chem"},{"key":"3352_CR200","doi-asserted-by":"publisher","first-page":"1324216","DOI":"10.3389\/fneur.2023.1324216","volume":"14","author":"S Fatima","year":"2024","unstructured":"Fatima S, Qaiser A, Andleeb S, Hashmi AH, Manzoor S. Navigating the brain: the role of Exosomal shuttles in precision therapeutics. Front Neurol. 2024;14:1324216.","journal-title":"Front Neurol"},{"key":"3352_CR201","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1007\/s00259-024-06690-1","volume":"51","author":"C Zhou","year":"2024","unstructured":"Zhou C, Zeng F, Yang H, Liang Z, Xu G, Li X, Liu X, Yang J. Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2024;51:2953\u201369.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3352_CR202","doi-asserted-by":"crossref","unstructured":"Yadav K, Vijayalakshmi R, Sahu KK, Sure P, Chahal K, Yadav R, Dubey A, Jha M, Pradhan M. Exosome-Based macromolecular neurotherapeutic drug delivery approaches in overcoming the Blood-Brain barrier for treating brain disorders. Eur J Pharm Biopharm. 2024;199:114298.","DOI":"10.1016\/j.ejpb.2024.114298"},{"key":"3352_CR203","doi-asserted-by":"publisher","first-page":"e1993","DOI":"10.1002\/wnan.1993","volume":"16","author":"H Zhao","year":"2024","unstructured":"Zhao H, Zhu L, Wang C, Yang Y. Extracellular vesicles-based theranostics for neurodegenerative diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024;16:e1993.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"3352_CR204","doi-asserted-by":"crossref","unstructured":"Greenberg ZF, Graim KS, He M. Towards artificial intelligence-enabled extracellular vesicle precision drug delivery. Adv Drug Deliv Rev. 2023;199:114974.","DOI":"10.1016\/j.addr.2023.114974"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03352-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03352-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03352-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T01:04:00Z","timestamp":1746234240000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03352-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":204,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3352"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03352-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}